Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
Flow Cytometry assay shows that Human CD27 Protein, Mouse IgG2a Fc Tag (Cat. No. CD7-H5257) can bind to Raji cells Surface Human CD70. The concentration of CD27 used is 10 μg/mL (Routinely tested).
Immobilized Human CD27, His Tag (Cat. No. CD7-H522b) at 2 μg/mL (100 μL/well) can bind Biotinylated Human CD27 Ligand Protein, Avitag,Fc Tag with a linear range of 1-31 ng/mL (QC tested).
The purity of Human CD27, His Tag (Cat. No. CD7-H522b) is more than 85% and the molecular weight of this protein is around 32-47 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Boserolimab | MK-5890 | Merck & Co Inc | Details | ||
| Anti-CD27 monoclonal antibody (Aduro Biotech) | BION-1402 | Phase 1 Clinical | Aduro Biotech Inc | Neoplasms | Details |
| Varlilumab | CDX-1127 | Phase 2 Clinical | Celldex Therapeutics | Lung Neoplasms; Cholangiocarcinoma; Plasmablastic Lymphoma; Lymphoma, Primary Effusion; Primary mediastinal B cell lymphoma; Astrocytoma; Bile Duct Neoplasms; Urologic Neoplasms; Lymphoma; Glioma; Prostatic Neoplasms; Gallbladder Neoplasms; Lymphoma, T-Cell; Burkitt Lymphoma; Lymphoma, Non-Hodgkin; Urogenital Neoplasms; Carcinoma, Non-Small-Cell Lung; Leukemia, Lymphocytic, Chronic, B-Cell; Adenocarcinoma; Melanoma; Lymphoma, Large B-Cell, Diffuse; Solid tumours; Ovarian Neoplasms; Biliary Tract Neoplasms; Kidney Neoplasms; Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Glioblastoma; Neoplasms; Lymphoma, B-Cell; Skin Neoplasms; Lymphomatoid Granulomatosis; Composite Lymphoma; Kidney Diseases; Triple Negative Breast Neoplasms; Oligodendroglioma; Urinary Bladder Neoplasms; Urologic Diseases; Lymphoma, Mantle-Cell | Details |
| LOR-S03 | CDX-527 | Phase 1 Clinical | Celldex Therapeutics | Solid tumours; Liver Neoplasms; Ovarian Neoplasms; Head and Neck Neoplasms; Stomach Neoplasms; Carcinoma, Renal Cell; Esophageal Neoplasms; Neoplasms; Microsatellite instability-high cancer; Urinary Bladder Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Peritoneal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.
A-Z
